Your health and wellness news reporter from Paraguay
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
May. 7, 2026
Paraguay Launches A New Golden Visa Program
May. 7, 2026
US report flags Kenya in global counterfeit goods as fake medicines, electronics surge
Indeterminate
Vivid Voice News
May. 6, 2026
Paraguay’s Pena visit underlines solid ties: MOFA
10 hours ago
What is hantavirus, and should I cancel my cruise?
Press releases
Publish your press release
May. 7, 2026
Knight Therapeutics Reports First Quarter 2026 Results
GlobeNewswire, Inc.
Increased 2026 revenue guidance from $510 million to $525 million Achieved record-high quarterly revenues, Adjusted EBITDA1 and Adjusted EBITDA per share1 since inception MONTREAL, May 07, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:...
Apr. 30, 2026
6 Steps Towards Engaging Wound Care Leadership As A Patient Brand & Financial Advantage
EIN Presswire
A Practical Solution For America’s Rural & Small Hospitals YARDLEY, PA, UNITED STATES, April 30, 2026 /EINPresswire.com/ -- There is an epidemic in health care in America, where the hospital itself, specifically rural and small hospitals, have...
Feb. 3, 2026
Global Liver Institute Drives Momentum Behind Landmark WHO Decision on Steatotic Liver Disease and NCDs
GlobeNewswire, Inc.
Geneva, Switzerland, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Today, at the 158th Executive Board meeting of the World Health Organization (WHO), Member States agreed to include the draft resolution “Steatotic liver disease: a missing piece in the global...
Jan. 21, 2026
AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast
GlobeNewswire, Inc.
Boston, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) is rapidly transforming how clinical trials are designed, conducted and monitored, bringing automation, predictive insights and real-time decision support into every phase of...
Jan. 14, 2026
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
GlobeNewswire, Inc.
AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related peptide (CGRP) antagonist treatment option for both pediatric and adult patients.1,2 Results from the SPACE trial...
Nov. 24, 2025
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
EIN Presswire
Expanded collaboration significantly broadens ACA Pharma’s ex-U.S. commercialization footprint for RYANODEX® NEW YORK, NY, UNITED STATES, November 24, 2025 /EINPresswire.com/ -- ACA Pharma today announced a significant expansion of their...
Video Stories
Discover Affinity Group Publishing
Sign up for:
Paraguay Health Dispatch
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
